Acta Scientific Dental Sciences (ISSN: 2581-4893)

Research Article Volume 4 Issue 7

Relationship between Inflammation-Related Markers in Peri-Implant Crevicular Fluid and Clinical Parameters in Partially Edentulous Saudi Arabian Diabetic Subjects

Shaden Aljabr1, Mansoorpdf/ASDS, Sami Shafik3, Naghshbandi Jafar4, Nasser Al-Daghri5, Osama Amer5 and Khalid Al-Hezaimi6*

1Postgraduate Student, Riyadh Elm University, Riyadh, Saudi Arabia
2Associate Professor, Vice Rector, Riyadh Elm University, Riyadh, Saudi Arabia
3Professor of Periodontics, Dental School, Riyadh Elm University, Riyadh, Saudi Arabia
4Head of Periodontology Department, School of Dentistry, Tishk International University, Erbil-Kurdistan, Iraq
5Chair for Biomarkers of Chronic Diseases, College of Science, King Saud University, Riyadh, Saudi Arabia
6Professor, Endodontics & Periodontics Department, School of Dentistry, Riyadh Elm University, Riyadh, Saudi Arabia.

*Corresponding Author: Khalid Al-Hezaimi, Professor, Endodontics & Periodont

Received: May 18, 2020; Published: June 30, 2020

×

Abstract

Introduction: A high prevalence of diabetes mellitus and dental caries in Saudi Arabian population is overwhelmingly reported. The aim of the study was to assess the following: 1) clinical findings of PD, BOP, and amount of keratinized tissue present around dental implant and 2) PICF levels of IL-1α, IL-1β, IL-6, and IL-8 in diabetic and non-diabetic partially edentulous Saudi Arabian subjects.

Materials and Methods: Total of 32 partially edentulous subjects, 16 diabetic and 16 non-diabetic, were included in the study. PICF samples were taken from peri-implant sulcus using paper point and PCR essays for IL-1α, IL-1β, IL-6, and IL-8 was performed. Clinical parameters of peri-implant PD, BOP and amount of keratinized tissue were recorded.

Results: Diabetic subjects had more significant BOP than non-diabetic counterparts (p-<0.001). No significant difference was found between diabetic and non-diabetic patients in the amount of keratinized tissue (P < 0.765). A significant high level of IL-6 in diabetic subjects when compared to healthy subjects (P < 0.033). No significant difference between diabetic and non-diabetic subjects in the serum level of IL-1α (P < 0.121), IL-1β (P < 0.171) and IL-8 (P < 0.223). A positive correlation between increased serum level of IL-1α, IL-1β, IL-6 and IL-8 with increased PD was determined.

Conclusion: PD, BOP and PICF IL-6 levels were found to be significantly higher in Saudi Arabian diabetic subjects compared to Saudi non-diabetic subjects. Also, a positive relation found between deep PD and four inflammatory markers which are IL-1α, IL-1β, IL-6 and IL-8.

Keywords: Implant; Diabetes; Peri-Implant Crevicular Fluid; IL-1α; IL-1β; IL-6; IL-8; Diabetic Saudi Arabian

×

References

  1. Birkedal‑Hansen H. “Role of cytokines and inflammatory mediators in tissue destruction”. Journal of Periodontal Research 28 (1993): 500‑
  2. Okada H and Murakami S. “Cytokine expression in periodontal health and disease”. Critical Reviews in Oral Biology and Medicine 9 (1998): 248‑
  3. Kurşunlu S., et al. “Gingival crevicular fluid interleukin-36β (-1F8), interleukin-36γ (-1F9) and interleukin-33 (-1F11) levels in different periodontal disease”. Archives of Oral Biology 60 (2015): 77-83.
  4. Faot F., et al. “Can Peri-Implant Crevicular Fluid Assist in the Diagnosis of Peri-Implantitis? A Systematic Review and Meta-Analysis”. Journal of Periodontology5 (2015): 631-645.
  5. Ishimi Y., et al. “IL 6 is produced by osteoblasts and induces bone resorption”. Journal of Immunology 145 (1990): 3297-3303.
  6. Uitto V., et al. “Proteolytic host cell enzymes in gingival crevice fluid”. Journal of Periodontology 31 (2000): 77-104.
  7. Figueredo C and Gustafsson A. “Increased amounts of laminin in GCF from untreated patients with periodontitis”. Journal of Clinical Periodontology 5 (2000): 313-318.
  8. Emrich L., et al. “Periodontal disease in non-insulin dependant diabetes mellitus”. Journal of Periodontology 62 (1991): 123-131.
  9. American Diabetes Association 2. Classification and Diagnosis of Diabetes”. Diabetes Care1 (2017): S11-S24.
  10. Wennström J., et al. “Oral rehabilitation with implant-supported fixed partial dentures in periodontitis-susceptible subjects”. Journal of Clinical Periodontology 31 (2004): 713-724.
  11. Javed F Al-Hezaimi K., et al. “Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis”. Cytokine 53 (2011): 8-12.
  12. Al-Daghri N., et al. “Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (riyadh cohort 2): a decade of an epidemic”. BMC Medicine 9 (2011): 76.
  13. Al Dawish M., et al. “Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature”. Current Diabetes Reviews 12 (2016): 359.
  14. Kardesxler L., et al. “Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes”. Inflammation Research 60 (2011): 143-151.
  15. Noh M., et al. “Assessment of IL 6, IL 8 and TNF α levels in the gingival tissue of patients with periodontitis”. Experimental and Therapeutic Medicine (2013): 847-851.
  16. Huang X., et al. “Hyperglucose contributes to periodontitis: Involvement of the NLRP3 pathway by engaging the innate immunity of oral gingival epithelium”. Journal of Periodontology. 86 (2015): 327-335.
  17. Shikama Y., et al. “Possible involvement of palmitate in pathogenesis of periodontitis”. Journal of Cellular Physiology 230 (2015): 2981-2989.
  18. Polak D and Shapira L. “An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes”. Journal of Clinical Periodontology 45 (2018): 150-166.
  19. Sanz M., et al. “Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology”. Journal of Clinical Periodontology 45 (2018): 138-149.
  20. Bartold PM and Haynes DR. “Interleukin‑6 production by human gingival fibroblasts”. Journal of Periodontal Research 26 (1991): 339‑
  21. Reinhardt R., et al. “Gingival fluid IL‑1 and IL‑6 levels in refractory periodontitis”. Journal of Clinical Periodontology 20 (1993): 225‑
  22. Botero J., et al. “Profiling of inflammatory cytokines produced by gingival fibroblasts after human cytomegalovirus infection”. Oral Microbiology and Immunology 23 (2008): 291‑
  23. Severino VO., et al. “Expression of IL-6, IL-10 IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitis”. Archives of Oral Biology 8 (2011): 823-828.
  24. Andriankaja OM., et al. “Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1beta and prostaglandin E (2) among non-smoking subjects with gingivitis and type 2 diabetes”. Journal of Periodontology 2 (2009): 307-316.
  25. Duarte P., et al. “Overexpression of interleukin-1beta and interleukin-6 may play an important role in periodontal breakdown in type 2 diabetic patients”. Journal of Periodontal Research 42 (2007): 377-381.
  26. Engebretson S., et al. “The influence of diabetes on gingival crevicular fluid beta-glucuronidase and interleukin-8”. Journal of Clinical Periodontology 33 (2006): 784-790.
  27. Bulut U., et al. “Interleukin-1 beta levels in gingival crevicular fluid in type 2 diabetes mellitus and adult periodontitis”. The Journal of Oral Science 43 (2001): 171-177.
  28. Salvi GE., et al. “Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients”. Journal of Periodontology 68 (1997): 127-135.
  29. Recker E., et al. “Cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients”. Journal of Periodontology 2 (2015): 264-272.
  30. Venza I., et al. “Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes”. Journal of Periodontology. 81 (2010): 99-108.
  31. Nowzari H., et al. “The profile of inflammatory cytokines in gingival crevicular fluid around healthy osseointegrated implants”. Clinical Implant Dentistry and Related Research 14 (2012): 546-552.
  32. Ata-Ali J., et al. “Clinical, microbiologic, and host response characteristics in patients with peri-implant mucositis”. The International Journal of Oral and Maxillofacial Implants 3 (2013): 883-890.
  33. Renvert S., et al. “Cytokine expression in peri-implant crevicular fluid in relation to bacterial presence”. Journal of Clinical Periodontology 7 (2015): 697-702.
  34. Ghassib I., et al. “Use of IL-1 β, IL-6, TNF-α, and MMP-8 biomarkers to distinguish peri-implant diseases: A systematic review and meta-analysis”. Clinical Implant Dentistry and Related Research 21 (2019): 190-207.
  35. Meyer S., et al. “Experimental mucositis and experimental gingivitis in persons aged 70 or over. Clinical and biological responses”. Clinical Oral Implants Research 28 (2017): 1005-1012.
  36. Liu J., et al. “High mobility group box 1 protein level as a novel biomarker for the development of peri-implant disease”. Scientific Reports 7 (2017): 7027.
×

Citation

Citation: Al-Hezaimi., et al. “Relationship between Inflammation-Related Markers in Peri-Implant Crevicular Fluid and Clinical Parameters in Partially Edentulous Saudi Arabian Diabetic Subjects” Acta Scientific Dental Sciences 4.7 (2020): 101-106.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.278

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US









ff

© 2024 Acta Scientific, All rights reserved.